{"transactions":[{"id":712498,"issuer":{"id":6146,"kind":"organization","name":"Niagen Bioscience, Inc."},"owners":[{"id":31396,"kind":"person","name":"Pamir Ozan","position":1,"cik":"0001834681","reported_name":"Pamir Ozan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-07-08T21:17:37.000Z","date":"2026-06-30","kind":"grant","planned":false,"acquired":true,"shares":4255,"price":2.71,"value":11531.05,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares acquired pursuant to the Issuer's Employee Stock Purchase Plan. The acquisition is exempt under Rule 16b-3(c) and 16b-3(d)."}],"balance_after":11627.159,"source":{"system":"sec-edgar","filing":"0001834681-26-000001","document":"wk-form4_1783545455.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1386570/000183468126000001/wk-form4_1783545455.xml","form_type":"4"}},{"id":884196,"issuer":{"id":6146,"kind":"organization","name":"Niagen Bioscience, Inc."},"owners":[{"id":31396,"kind":"person","name":"Pamir Ozan","position":1,"cik":"0001834681","reported_name":"Pamir Ozan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Options (right to buy)","published_at":"2026-02-24T21:46:19.000Z","date":"2026-02-19","kind":"grant","planned":false,"acquired":true,"shares":62131,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-fourth of the shares subject to the option shall vest on each anniversary of the grant date."}],"balance_after":62131,"derivative":{"exercise_price":4.94,"exercise_date":"2027-02-19","expiration_date":"2036-02-18","underlying":"Common Stock","underlying_shares":62131},"source":{"system":"sec-edgar","filing":"0001628280-26-011160","document":"wk-form4_1771969576.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1386570/000162828026011160/wk-form4_1771969576.xml","form_type":"4"}},{"id":997559,"issuer":{"id":6146,"kind":"organization","name":"Niagen Bioscience, Inc."},"owners":[{"id":31396,"kind":"person","name":"Pamir Ozan","position":1,"cik":"0001834681","reported_name":"Pamir Ozan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-11-17T13:23:28.000Z","date":"2025-11-14","kind":"purchase","planned":false,"acquired":true,"shares":2220.443,"price":6.85,"value":15210.03455,"ownership":{"direct":false,"nature":"The reported securities are held by the reporting person's spouse."},"balance_after":2220.443,"source":{"system":"sec-edgar","filing":"0001834681-25-000005","document":"wk-form4_1763385804.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1386570/000183468125000005/wk-form4_1763385804.xml","form_type":"4"}},{"id":997558,"issuer":{"id":6146,"kind":"organization","name":"Niagen Bioscience, Inc."},"owners":[{"id":31396,"kind":"person","name":"Pamir Ozan","position":1,"cik":"0001834681","reported_name":"Pamir Ozan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-11-17T13:23:28.000Z","date":"2025-11-14","kind":"purchase","planned":false,"acquired":true,"shares":4464.962,"price":6.81,"value":30406.39122,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The weighted average purchase price for the transaction reported was $6.81, and the range of prices were between $6.7975 and $6.82, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased at each separate price within the range above will be provided."}],"balance_after":7372.159,"source":{"system":"sec-edgar","filing":"0001834681-25-000005","document":"wk-form4_1763385804.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1386570/000183468125000005/wk-form4_1763385804.xml","form_type":"4"}},{"id":1266846,"issuer":{"id":6146,"kind":"organization","name":"Niagen Bioscience, Inc."},"owners":[{"id":31396,"kind":"person","name":"Pamir Ozan","position":1,"cik":"0001834681","reported_name":"Pamir Ozan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Options (right to buy)","published_at":"2025-02-14T23:18:14.000Z","date":"2025-02-12","kind":"grant","planned":false,"acquired":true,"shares":17230,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the shares subject to the option shall vest on February 12, 2026 and the remaining shares subject to the option shall vest in a series of 24 equal monthly installments thereafter."}],"balance_after":17230,"derivative":{"exercise_price":5.48,"exercise_date":"2026-02-12","expiration_date":"2035-02-11","underlying":"Common Stock","underlying_shares":17230},"source":{"system":"sec-edgar","filing":"0001628280-25-005854","document":"wk-form4_1739575087.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1386570/000162828025005854/wk-form4_1739575087.xml","form_type":"4"}},{"id":1352393,"issuer":{"id":6146,"kind":"organization","name":"Niagen Bioscience, Inc."},"owners":[{"id":31396,"kind":"person","name":"Pamir Ozan","position":1,"cik":"0001834681","reported_name":"Pamir Ozan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-11-25T12:28:56.000Z","date":"2024-11-22","kind":"purchase","planned":false,"acquired":true,"shares":2907.197,"price":7.36,"value":21396.96992,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The weighted average purchase price for the transaction reported was $7.36, and the range of prices were between $7.345 and $7.36, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased at each separate price within the range above will be provided."}],"balance_after":2907.197,"source":{"system":"sec-edgar","filing":"0001628280-24-049079","document":"wk-form4_1732537730.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1386570/000162828024049079/wk-form4_1732537730.xml","form_type":"4"}},{"id":1382326,"issuer":{"id":6146,"kind":"organization","name":"Niagen Bioscience, Inc."},"owners":[{"id":31396,"kind":"person","name":"Pamir Ozan","position":1,"cik":"0001834681","reported_name":"Pamir Ozan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Options (right to buy)","published_at":"2024-10-23T21:04:08.000Z","date":"2024-10-21","kind":"grant","planned":false,"acquired":true,"shares":146544,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the shares subject to the option shall vest on October 21, 2025 and the remaining shares subject to the option shall vest in a series of 24 equal monthly installments thereafter."}],"balance_after":146544,"derivative":{"exercise_price":3.46,"exercise_date":"2025-10-21","expiration_date":"2034-10-20","underlying":"Common Stock","underlying_shares":146544},"source":{"system":"sec-edgar","filing":"0001628280-24-043462","document":"wk-form4_1729717442.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1386570/000162828024043462/wk-form4_1729717442.xml","form_type":"4"}},{"id":1787203,"issuer":{"id":7020,"kind":"organization","name":"FORUM MARKETS Inc"},"owners":[{"id":31396,"kind":"person","name":"Pamir Ozan","position":1,"cik":"0001834681","reported_name":"Pamir Ozan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-09-06T22:30:29.000Z","date":"2023-09-04","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Stock Options were granted to the Reporting Person pursuant to the Issuer's First Amended and Restated 2022 Omnibus Incentive Plan in consideration for services to be rendered as Chief Financial Officer. Exempt from Section 16(b) pursuant to Rule 16b-3."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest at the rate of 1/12th of such options ratably on a monthly basis over the following 12 months on the last day of each calendar month (beginning September 30, 2023), subject to the Reporting Person's continued service to the Company on such vesting dates."}],"balance_after":15000,"derivative":{"exercise_price":0.67,"expiration_date":"2033-09-04","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001213900-23-074485","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1690080/000121390023074485/ownership.xml","form_type":"4"}},{"id":1884672,"issuer":{"id":7020,"kind":"organization","name":"FORUM MARKETS Inc"},"owners":[{"id":31396,"kind":"person","name":"Pamir Ozan","position":1,"cik":"0001834681","reported_name":"Pamir Ozan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2023-05-19T12:30:11.000Z","date":"2023-05-18","kind":"purchase","planned":false,"acquired":true,"shares":5162.077,"price":1.01,"value":5213.69777,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $0.9801 to $1.02, inclusive. The price reported above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":8983.077,"source":{"system":"sec-edgar","filing":"0001213900-23-041328","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1690080/000121390023041328/ownership.xml","form_type":"4"}},{"id":2475566,"issuer":{"id":7020,"kind":"organization","name":"FORUM MARKETS Inc"},"owners":[{"id":31396,"kind":"person","name":"Pamir Ozan","position":1,"cik":"0001834681","reported_name":"Pamir Ozan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CFO"}}],"security":"Common Stock","published_at":"2021-12-13T13:31:58.000Z","date":"2021-12-10","kind":"purchase","acquired":true,"shares":3800,"price":3.87,"value":14706.0,"ownership":{"direct":true},"balance_after":76408,"source":{"system":"sec-edgar","filing":"0001213900-21-064876","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1690080/000121390021064876/ownership.xml","form_type":"4"}},{"id":2813901,"issuer":{"id":7020,"kind":"organization","name":"FORUM MARKETS Inc"},"owners":[{"id":31396,"kind":"person","name":"Pamir Ozan","position":1,"cik":"0001834681","reported_name":"Pamir Ozan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-03T21:31:36.000Z","date":"2021-02-26","kind":"grant","acquired":true,"shares":180000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Stock Options were granted to the Reporting Person pursuant to the Issuer's 2020 Omnibus Incentive Plan in consideration for services to be rendered as Interim Chief Financial Officer. Exempt from Section 16(b) pursuant to Rule 16b-3."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest at the rate of (a) 1/5th of such options on the grant date; and (b) 4/5th of such options vesting ratably on a monthly basis over the following 36 months on the last day of each calendar month, subject to the Reporting Person's continued service to the Company on such vesting dates."}],"balance_after":180000,"derivative":{"exercise_price":4.43,"expiration_date":"2031-02-26","underlying":"Common Stock","underlying_shares":180000},"source":{"system":"sec-edgar","filing":"0001213900-21-013186","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1690080/000121390021013186/ownership.xml","form_type":"4"}}]}